Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of <i>Coptis chinensis</i> Franchin Polycystic Ovary Syndrome

<div>Compounds identification and the effect of the <i>C. chinensis</i> on the experimental PCOS model mice. (a) The phytochemical compositions identification in the WZYZP by UHPLC-QTOF-MS/MS in the positive ion mode and negative ion mode. (b) Effect of the different doses of <i>C. chinensis</i> on body weight of mice. (c) HE staining to evaluate the effect of the <i>C. chinensis</i> on mouse ovarian histological changes, above magnification ×40, 100.</div>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of <i>Coptis chinensis</i> Franchin Polycystic Ovary Syndrome 

Figure 7 | Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of Coptis chinensis Franchin Polycystic Ovary Syndrome 